VIVO Ventures VI Affiilates Fund, L.P., 10% Owner at Carbylan Therapeutics, Inc. (CBYL), bought 1,030,642 shares at $5.00 ($5.1M) on 2015-04-14, disclosed to the SEC on 2015-04-14.
Open-market purchase of $5.1M CBYL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 18,142 | $0 | 0.0% |
| 2 | $5.00 | 7,364 | $37K | 0.7% |
| 3 | $5.00 | 1,005,136 | $5.0M | 99.3% |
| Total | $4.91 avg | 1,030,642 | $5.1M | 100% |